Two Global New Drugs, Viekirax Priced In Japan
This article was originally published in PharmAsia News
Executive Summary
The latest reimbursement price listing of drugs in Japan clears the way for the first launches worldwide of two new molecules for thrombocytopenia and diabetes, and also for the local launch of an important new hepatitis C therapy.